Home › Overweight › Nebraska › Omaha
Overweight clinical trials in Omaha, NE
6 studies for Overweight are looking for participants at sites in and around Omaha (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
RecruitingPhase 3
- University Of Nebraska Medical Center, Omaha
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
RecruitingPhase 3
- Omaha Childrens Hospital, Omaha
- Velocity Clinical Research, Omaha
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
RecruitingPhase 3
- Research Site, Omaha
- Research Site, Omaha
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RecruitingPhase 3
- University of Nebraska Medical Center, Omaha
- Primary Clinical Research, Papillion · 9 mi away
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
RecruitingPhase 3Healthy volunteers welcome
- ACCOMPLISH-2 Research Site, Omaha
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
RecruitingPhase 3
- ACCOMPLISH-1 Research Site, Omaha
Overweight trials in other cities
- Houston, TX33 studies
- San Antonio, TX33 studies
- Chicago, IL28 studies
- Orlando, FL25 studies
- Las Vegas, NV23 studies
- Miami, FL23 studies
- Dallas, TX20 studies
- Atlanta, GA20 studies
- Jacksonville, FL19 studies
- Washington, DC19 studies
- New York City, NY19 studies
- Austin, TX18 studies
Other studies in Omaha
- Prostate Cancer28 studies
- Non-Small Cell Lung Cancer25 studies
- Breast Cancer23 studies
- Cancer (all types)19 studies
- Colorectal Cancer19 studies
- Multiple Myeloma16 studies
- Ovarian Cancer15 studies
- Pancreatic Cancer14 studies
- Metastatic Cancer14 studies
- Non-Hodgkin Lymphoma14 studies
- Lung Cancer13 studies
- Heart Failure13 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.